Related Experiment Videos
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays
1Unit of Molecular Pathology, International Agency for Research on Cancer (IARC), Lyon, France.
Cancer Research
|January 13, 2001
Summary
This study identified significant gene expression changes in diffuse astrocytomas, revealing potential molecular markers for this brain tumor. Further research is needed to confirm their role in glial cell transformation.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Diffuse astrocytoma (WHO grade II) is a slow-growing brain tumor with a propensity for malignant progression.
- The molecular underpinnings of diffuse astrocytoma remain largely uncharacterized, with p53 mutations being the most frequently identified alteration (>60%).
Purpose of the Study:
- To investigate global gene expression alterations in diffuse astrocytoma.
- To identify novel genetic markers associated with diffuse astrocytoma development and progression.
Main Methods:
- Gene expression profiling using cDNA expression arrays on 11 diffuse astrocytoma samples.
- Validation of gene expression changes using semiquantitative reverse transcription-PCR.
- Immunohistochemical analysis of SPARC protein expression in tumor tissues.
Main Results:
- Six genes (TIMP3, c-myc, EGFR, DR-nm23, nm23-H4, GDNPF) showed consistent expression in diffuse astrocytomas compared to normal brain tissue.
- Seven genes were significantly upregulated and eleven genes were downregulated in a subset of diffuse astrocytoma cases.
- SPARC protein exhibited cytoplasmic immunoreactivity in neoplastic cells of all analyzed diffuse astrocytomas.
Conclusions:
- Diffuse astrocytomas exhibit substantial alterations in gene expression profiles.
- Identified gene expression changes may contribute to the understanding of glial cell transformation.
- Further studies are warranted to elucidate the causal role of these genetic alterations in astrocytoma pathogenesis.